Skip to main content

James Hassard

Crinetics Pharmaceuticals, Inc.

Equibles does not estimate personal net worth.

About James Hassard

Crinetics Pharmaceuticals, Inc. reported in an 8-K filed September 17, 2024 that James Hassard was terminated as Chief Commercial Officer, effective October 14, 2024. Crinetics Pharmaceuticals, Inc. reported in an 8-K filed March 1, 2022 that James Hassard was appointed Chief Commercial Officer, effective February 28, 2022. Arrowhead Pharmaceuticals, Inc. reported in an 8-K filed August 27, 2021 that James Hassard was terminated as Chief Commercial Officer, effective August 23, 2021. The proxy statement of Arrowhead Pharmaceuticals, Inc. reports total compensation of $7,918,296 for James Hassard in fiscal 2020, including a base salary of $302,404. Disclosed compensation is on record for 3 fiscal years. Crinetics Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector.

“On September 13, 2024, Crinetics Pharmaceuticals, Inc. (the “Company”) determined that James Hassard will separate from the Company and will cease serving as the Chief Commercial Officer, effective October 14, 2024.”
Crinetics Pharmaceuticals, Inc. Form 8-K, filed September 17, 2024 · Read the filing
“On March 1, 2022, Crinetics Pharmaceuticals, Inc. (the “Company” or “Crinetics”) announced the appointment of James Hassard as the Company’s Chief Commercial Officer, which was effective as of February 28, 2022.”
Crinetics Pharmaceuticals, Inc. Form 8-K, filed March 1, 2022 · Read the filing

Affiliation history

  • Crinetics Pharmaceuticals, Inc.

    SEC 8-K

    Current

    2022-02-28–present

  • Start not stated–2021-08-23

  • Crinetics Pharmaceuticals, Inc.

    Proxy statement

    Start not stated–2024-10-14

Company network

Crinetics Pharmaceuticals, Inc.

Current role

Biotechnology · Healthcare

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2020 Arrowhead Pharmaceuticals, Inc. (ARWR) $302,404 $7,918,296
2019 Arrowhead Pharmaceuticals, Inc. (ARWR) — —
2018 Arrowhead Pharmaceuticals, Inc. (ARWR) — —

Recent activity